Refractory Lung Diseases: From Cellular Structures, Molecular Mechanisms to Therapeutic Strategies
Pediatric Discovery · 2026-03 · 4 (1)
DOI: 10.1002/pdi3.70040 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Discovery, online erschienen am 19.03.2026. Verfasst von Yiheng Qiu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Education Key Laboratory of Diagnostic Medicine, and Department of Clinical Biochemistry School of Clinical Laboratory Medicine Chongqing…. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Refractory lung diseases (RLDs) encompass a spectrum of progressive pulmonary disorders, including acute respiratory distress syndrome (ARDS), bronchopulmonary dysplasia (BPD), and idiopathic pulmonary fibrosis (IPF). These conditions are defined by poor responsiveness to current therapeutic interventions and pose substantial clinical challenges, primarily due to their high morbidity and mortality rates. This review synthesizes the current understanding of the molecular mechanisms underlying RLDs and explores promising therapeutic strategies. A core feature of RLD pathogenesis is the disruption of alveolar microenvironmental homeostasis, which triggers a bidirectional vicious cycle between structural damage and disease progression. This homeostatic collapse is driven by interconnected pathological networks—including oxidative stress coupled with mitochondrial dysfunction, inflammatory immune dysregulation, and mechanical stress‐induced extracellular matrix (ECM) remodeling—all of which are elaborated in this review. Collectively, these pathological processes contribute to therapeutic resistance. Based on these mechanistic insights, potential therapeutic approaches are discussed, such as antioxidant therapies (e.g., the mitochondria‐targeted antioxidant Mitoquinone mesylate [MitoQ]) and antifibrotic agents (e.g., pirfenidone, nintedanib, as well as emerging strategies targeting Wnt pathway modulation). Additionally, the critical significance of early diagnosis and personalized precision medicine is emphasized. Future research should focus on a deeper characterization of the dynamic alterations within the alveolar microenvironment under pathological conditions, with the aim of developing more precise diagnostic tools and targeted therapeutic strategies. Ultimately, the therapeutic goal for RLDs should shift from mere symptom management to achieving pathological reversal.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ministry of Education Key Laboratory of Diagnostic Medicine, and Department of Clinical Biochemistry School of Clinical Laboratory Medicine Chongqing Medical University Chongqing China.
- Department of Orthopaedic Surgery and Rehabilitation Medicine Molecular Oncology Laboratory The University of Chicago Medical Center Chicago Illinois USA.
- Pritzker School of Medicine The University of Chicago Medical Center Chicago Illinois USA.
- Department of Cardiology the Affiliated University-town Hospital of Chongqing Medical University Chongqing China.
- Stem Cell Biology and Therapy Laboratory of the Pediatric Research Institute the National Clinical Research Center for Child Health and Disorders, and Ministry of Education Key Laboratory of Child Development and Disord…
ORCID-Profile: Yi Zhu
Zitieren
APA
Qiu, Y., Dong, X., Zhu, Y., Miranda, N., Chukwura, A., Peng, Y., Zhao, S., Xiang, M., McGuire, P., Zou, A., Zhang, L., Fan, J., & Zhang, L. (2026). Refractory Lung Diseases: From Cellular Structures, Molecular Mechanisms to Therapeutic Strategies. Pediatric Discovery, 4(1). https://doi.org/10.1002/pdi3.70040
Vancouver
Qiu Y, Dong X, Zhu Y, Miranda N, Chukwura A, Peng Y, et al. Refractory Lung Diseases: From Cellular Structures, Molecular Mechanisms to Therapeutic Strategies. Pediatric Discovery. 2026;4(1). doi:10.1002/pdi3.70040
BibTeX
@article{Qiu2026,
author = {Qiu, Yiheng and Dong, Xiangyu and Zhu, Yi and Miranda, Nicole and Chukwura, Awele and Peng, Yan and Zhao, Sarina and Xiang, Michelle and McGuire, Peyton and Zou, Ava and Zhang, Lucas and Fan, Jiaming and Zhang, Linghuan},
title = {Refractory Lung Diseases: From Cellular Structures, Molecular Mechanisms to Therapeutic Strategies},
journal = {Pediatric Discovery},
year = {2026},
volume = {4},
number = {1},
doi = {10.1002/pdi3.70040}
}
EUVIMED